2-26402035-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_145038.5(DRC1):c.46G>A(p.Glu16Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000992 in 1,612,852 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_145038.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DRC1 | NM_145038.5 | c.46G>A | p.Glu16Lys | missense_variant | 1/17 | ENST00000288710.7 | NP_659475.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DRC1 | ENST00000288710.7 | c.46G>A | p.Glu16Lys | missense_variant | 1/17 | 2 | NM_145038.5 | ENSP00000288710 | P1 | |
DRC1 | ENST00000421869.5 | c.46G>A | p.Glu16Lys | missense_variant, NMD_transcript_variant | 1/8 | 1 | ENSP00000414375 | |||
DRC1 | ENST00000649059.1 | c.34G>A | p.Glu12Lys | missense_variant, NMD_transcript_variant | 1/16 | ENSP00000497543 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152214Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000808 AC: 2AN: 247584Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 134510
GnomAD4 exome AF: 0.00000753 AC: 11AN: 1460638Hom.: 0 Cov.: 30 AF XY: 0.00000551 AC XY: 4AN XY: 726528
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152214Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74362
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 18, 2023 | This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 16 of the DRC1 protein (p.Glu16Lys). This variant is present in population databases (rs149082901, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with DRC1-related conditions. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at